3 Biotech Stocks to Watch in 2019 [The Motley Fool]
Vertex Pharmaceuticals Incorporated (VRTX)
Last vertex pharmaceuticals incorporated earnings: 4/29 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.vrtx.com
Company Research
Source: The Motley Fool
3 Biotech Stocks to Watch in 2019 Biotech stocks can deliver eye-popping returns when clinical trials pan out and regulators approve new drugs. But most trials fail, and there aren't any guarantees of a regulatory OK. Uncertainty over trial outcomes and Food and Drug Administration (FDA) go/no-go decisions make Sarepta Therapeutics NASDAQ:SRPT bluebird bio NASDAQ:BLUE Vertex Pharmaceuticals NASDAQ:VRTX Expanding its lead Sarepta Therapeutics broke new ground when it won approval Image source: Getty Images. DMD is caused by mutations that result in inadequate dystrophin production. Sadly, most DMD patients lose the ability to walk in their teens because of muscle loss and pass away in their 0s because of cardiovascular complications caused by the loss of heart muscle. In an attempt to improve outcomes, Exondys skips over mutations located at the gene segment known as exon so patients can produce more useful dystrophin. Unfortunately, only about % of DMD patients have such mutations,
Show less
Read more
Impact Snapshot
Event Time:
VRTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VRTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VRTX alerts
High impacting Vertex Pharmaceuticals Incorporated news events
Weekly update
A roundup of the hottest topics
VRTX
News
- Vertex Pharmaceuticals (VRTX) Rises As Market Takes a Dip: Key Facts [Yahoo! Finance]Yahoo! Finance
- Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.MarketBeat
- Vertex Announces FDA Clearance of Investigational New Drug Application for VX-407 for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD) [Yahoo! Finance]Yahoo! Finance
- Vertex Announces FDA Clearance of Investigational New Drug Application for VX-407 for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)Business Wire
- Vertex Pharmaceuticals: Diversifying Its Drug Portfolio For Future Growth [Seeking Alpha]Seeking Alpha
VRTX
Earnings
- 2/5/24 - Beat
VRTX
Sec Filings
- 2/27/24 - Form 4
- 2/27/24 - Form 4
- 2/27/24 - Form 4
- VRTX's page on the SEC website